Silver Book Fact

Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.

Lichtenberg, Frank R. The Expanding Pharmaceutical Arsenal in the War on Cancer. National Bureau of Economic Research. February 2004; Working Paper No. 10328. http://www.nber.org/papers/w10328

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
National Bureau of Economic Research
Publication Date
February 2004
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Gains in healthy years of life and social value from cancer R&D
     
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.  
  • Low dose CT screening for lung cancer costs less than $200 per person, and surgery for stage I lung cancer is less than 1/2 the cost of late-stage treatment.  
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • Pathogens cause around two million cancer cases worldwide each year. Ninety percent of these cases are attributable to Helicobacter pylori (H Pylori), hepatitis B virus (HBV), hepatitis C virus (HCV),…